MCLAURIN JOANNE has a total of 44 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and measurement are EISENBACH-SCHWARTZ MICHAL, ECONUGENICS INC and IPSEN LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | Canada | 7 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | Australia | 4 | |
#6 | Japan | 4 | |
#7 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Mclaurin Joanne | 43 |
#2 | Cruz Antonio | 2 |
Publication | Filing date | Title |
---|---|---|
US2011105626A1 | Use of cyclohexanehexol derivatives for the treatment of polyglutamine diseases | |
WO2008124929A1 | USE OF CYCLOHEXANEHEXOL DERIVATIVES IN THE TREATMENT OF α-SYNUCLEINOPATHIES | |
US2010144891A1 | Use of cyclohexanehexol derivatives in the treatment of amyotrophic lateral sclerosis | |
US2007197452A1 | Treatment of amyloid-related diseases | |
EP1993523A2 | Compositions and methods for treatment of disorders of protein aggregation | |
AU2005306531A1 | Compositions comprising scyllo-inositol derivatives and methods to treat disorders of protein aggregation | |
US7521481B2 | Methods of preventing, treating and diagnosing disorders of protein aggregation |